You’ve probably heard of Adderall, the latest flavour of the month in the world of performance-enhancing drugs for athletes. If you haven’t, you surely will soon enough because we are expected to believe a substance used to treat symptoms of attention deficit hyperactivity disorder (ADHD) is medically required twice as often by baseball players as by people in general. Does that make sense?
You’ve probably heard of Adderall, the latest flavour of the month in the world of performance-enhancing drugs for athletes. If you haven’t, you surely will soon enough because we are expected to believe a substance used to treat symptoms of attention deficit hyperactivity disorder (ADHD) is medically required twice as often by baseball players as by people in general. Does that make sense?
This is the saddest moment in my 45 year career of studying, practicing, and teaching psychiatry. The Board of Trustees of the American Psychiatric Association has given its final approval to a deeply flawed DSM 5 containing many changes that seem clearly unsafe and scientifically unsound. My best advice to clinicians, to the press, and to the general public – be skeptical and don’t follow DSM 5 blindly down a road likely to lead to massive over-diagnosis and harmful over-medication. Just ignore the ten changes that make no sense.
This brochure is an overview of the side effects of common psychiatric drugs and includes information on drug regulatory agency warnings, studies and other…
A “model” program that was part of a controversial plan to screen all US citizens for mental illness has announced that it is closing down.
On 15 November, TeenScreen, a program to detect depression in young people, announced on its website: “The National Center will be winding down its program at the end of this year.”